在患有先天性中断的下静脉卡瓦患者中,通过转肝接入关闭左心室尾
Tai H Pham1, Akshay R Kamath1, Jason H Rogers1
1University of California-Davis, Division of Cardiovascular Medicine, Davis, California, USA.
JACC. Case reports
|December 9, 2025
概括
左心房尾阻塞 (LAAO) 对于心房患者中风预防至关重要. 通过肝脏的方法提供了一个可行的替代方案,当标准的输血道访问是不可能的.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 左心房尾阻塞 (LAAO) 适用于患有非膜心房的患者,有血栓栓塞性中风风险.
- 无法耐受长期抗凝药的患者是LAAO的候选人.
- 在某些病例中,标准的移植方法可能是不可接受的.
研究的目的:
- 介绍一个成功的LAAO的案例,使用一种跨肝的方法.
- 当标准方法违反时,突出一个替代的访问策略.
主要方法:
- 一名心房和中断下腔静脉 (IVC) 的患者接受了LAAO.
- 在装置植入过程中采用了跨肝的方法.
- 一个31毫米的Watchman FLX Pro设备成功部署.
主要成果:
- 成功的LAAO通过跨肝路线实现.
- 通过肝脏的方法绕过了中断的IVC带来的挑战.
结论:
- 通过肝脏的方法是LAAO的可行的替代方案,当转静脉方法是不可行的.
- 程序前的规划和技术考虑是成功跨肝 LAAO 的关键.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


